Ethos Technologies (LIFE) FCF Margin (2025 - 2026)
Ethos Technologies (LIFE) posted FCF Margin of 18.64% for Q2 2026, up 16.65% on a QoQ basis from 15.98% in Q1 2026, and up 409.0% year-over-year from 3.66% in Q2 2025.
Powered by 
Analysis
Ethos Technologies (LIFE) FCF Margin (2025 - 2026) Analysis & Trends
Ethos Technologies has reported FCF Margin for 2 years, with the latest figure at 18.64% in Q2 2026.
- On a quarterly basis, FCF Margin rose 409.0% year-over-year to 18.64% in Q2 2026; TTM through Jun 2026 was 15.83%, a N/A change from a year earlier, with the FY2025 full-year figure at 8.96%, up 1354.0% from the prior year.
- FCF Margin was 18.64% for Q2 2026 at Ethos Technologies, up from 15.98% in the prior quarter.
- The five-year high for FCF Margin was 18.64% in Q2 2026, with the low at 11.1% in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Hinge Health | 7.05 Bn | 6.66 Bn | 183.95 Mn | 46.84% |
| 2 | Hims & Hers Health | 6.40 Bn | 5.56 Bn | 480.80 Mn | -8.21% |
| 3 | Ethos Technologies | 2.50 Bn | 2.33 Bn | 185.54 Mn | 18.64% |
| 4 | Omada Health | 1.29 Bn | 1.07 Bn | 63.79 Mn | 2.83% |
| 5 | Teladoc Health | 1.11 Bn | 338.96 Mn | 416.09 Mn | 6.04% |
| 6 | Talkspace | 870.58 Mn | 779.48 Mn | 24.80 Mn | 13.39% |
| 7 | Akso Health | 218.21 Mn | 218.04 Mn | - | - |
| 8 | LifeMD | 141.21 Mn | 141.21 Mn | - | - |
| 9 | eHealth | 29.24 Mn | -71.81 Mn | - | -21.30% |
| 10 | Mangoceuticals | 6.61 Mn | 6.37 Mn | 44,215.00 | -378.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.64% |
| Mar 31, 2026 | 15.98% |
| Jun 30, 2025 | 14.55% |
| Mar 31, 2025 | 11.10% |